WBB Cuts Pluristem Therapeutics (PSTI) from Spec Buy to Hold
Tweet
Share
E-mailGet Alerts PSTI Hot Sheet
Price: $1.00 --0%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
WBB Securities downgraded Pluristem Therapeutics (NASDAQ: PSTI) from Speculative Buy to Hold Tuesday morning.
The stock is down 2.9 percent to $3.30 at last check.
For an analyst ratings summary and ratings history on Pluristem Therapeutics click here. For more ratings news on Pluristem Therapeutics click here.
The stock is down 2.9 percent to $3.30 at last check.
For an analyst ratings summary and ratings history on Pluristem Therapeutics click here. For more ratings news on Pluristem Therapeutics click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
